News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Protagen AG Closes Second Round Of Financing With Old And New Investors
May 8, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
The MIG AG Funds 1 and 3 in Munich are investing into Protagen AG. In cooperation with the co-investor S-Venture Capital Dortmund GmbH, EUR 3,3 Million will be invested into Protagen AG.
Twitter
LinkedIn
Facebook
Email
Print
Startups
Europe
ProtaGene
MORE ON THIS TOPIC
Business
Karyopharm files for bankruptcy, looks to merger with Ayrmid for life raft
November 2, 2026
·
3 min read
·
Angela Gabriel
Manufacturing
Sun Pharma stops eye-care drug production at Indian plant amid quality issues
November 2, 2026
·
2 min read
·
Nick Paul Taylor
Multiple sclerosis
Tiziana touts multiple sclerosis win at lower dose as high dose misses mark
November 2, 2026
·
2 min read
·
Gabrielle Masson
Layoff Tracker
Vistagen cuts workforce for second time in 2026
November 2, 2026
·
114 min read
·
BioSpace Editorial Staff
